Genome Group SRL
Genome Group reported total assets of 34,762 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Genome Group shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Genome Group's annual accounts
| 2025 | |
|---|---|
| Net result | 23,312 € |
| Equity | 15,500 € |
| Cash | 26,467 € |
| EBITDA | 31,551 € |
| Total assets | 34,762 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
Genome Group's financial analysis
- Solvency44.6%sector median: 50.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Genome Group
Genome Group's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1025.801.526
- VAT number
- BE1025801526
- Peppol
- Registered · 0208:1025801526 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jul 2025
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Public relations and communication activities (NACE 73300)
Genome Group (SRL) has been based in Uccle since 2025, active in: public relations and communication activities. For 2025, it reports a net profit of 23,312 € and equity of 15,500 €; its revenue is not published. Its solvency stands at 44.6%, below the median of its sector (50.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Genome Group
Companies in the same business, of comparable size and area, outside its group.
- L&I Partners Public relations and communication activities Kraainem · balance sheet 2,340 €
- DMJ Services Public relations and communication activities Sint-Lievens-Houtem · balance sheet 37,056 €
- Elite Group Public relations and communication activities Watermael-Boitsfort · balance sheet 26,332 €
- Vina Consulting Public relations and communication activities Anderlecht · balance sheet 34,032 €
- VS Paradise Public relations and communication activities Namur · balance sheet 68,102 €
- D. Hekkers Public relations and communication activities Uccle · balance sheet 37,903 €
- Intellworks Public relations and communication activities Brussels · balance sheet 32,473 €
- Horses & Events Public relations and communication activities Rijkevorsel · balance sheet 39,912 €
Frequently asked questions about Genome Group
What is the revenue of Genome Group?
Genome Group files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Genome Group?
In Belgium, the VAT number is the company number prefixed with BE: BE1025801526 for Genome Group, if the company is VAT-registered. Its company number (CBE) is 1025.801.526.
Where is the registered office of Genome Group?
According to the CBE register, the registered office of Genome Group is in 1180 Uccle.
What is the equity of Genome Group?
At the close of the 2025 financial year, the equity of Genome Group amounts to 15,500 €, a solvency of 44.6% of total assets.
Who manages Genome Group?
The register lists 1 active mandates at Genome Group. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Genome Group
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →